HK Stock Market Move | TSINGTAO BREW (00168) rose more than 3% after the performance results. Net profit attributable to shareholders in the first quarter increased by 5.2% year-on-year, with an increase in the promotion of classic and high-end products.
Qingdao Beer Company (00168) rose more than 3% after its performance report. As of the time of publication, it rose by 3.38% to HKD 52.05, with a trading volume of HKD 82.19 million.
TSINGTAO BREW (00168) rose more than 3% after the performance, with a 3.38% increase to HK$52.05 at the time of writing, with a turnover of HK$82.191 million.
On the news front, on April 27, TSINGTAO BREW released its first quarter report for 2026. During the reporting period, the company focused on high-quality development, targeted market regions, and precise consumption characteristics to promote regional market development through differentiated strategies; actively reducing costs and controlling expenses to achieve operational development and efficiency improvement. In the first quarter of 2026, the company cumulatively achieved product sales of 2.202 million kiloliters, with a revenue of RMB 10.29 billion, a decrease of 1.54% year-on-year; and a net profit attributable to the shareholders of the listed company of RMB 1.8 billion, an increase of 5.2% year-on-year.
During the reporting period, the company continued to advance brand optimization and product structure upgrade, focusing on Tsingtao Brewery's classic and wheat beer products, intensifying the cultivation and promotion of classic and above mid-to-high-end products, accelerating the development of new categories such as whole grain, craft beer, zero-sugar light calorie, non-alcoholic, low-alcohol, steadily improving product structure and profitability. During the reporting period, the main brand Tsingtao Brewery achieved product sales of 1.381 million kiloliters, an increase of 0.4% year-on-year; and mid-to-high-end products above achieved sales of 1.042 million kiloliters, an increase of 3.1% year-on-year.
Related Articles

J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.

UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.

LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.






